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Macrophages and Myeloid Dendritic Cells, but Not
Plasmacytoid Dendritic Cells, Produce IL-10 in Response to
MyD88- and TRIF-Dependent TLR Signals, and
TLR-Independent Signals1
André Boonstra,* Ricardo Rajsbaum,* Mary Holman,* Rute Marques,* Carine Asselin-Paturel,†
João Pedro Pereira,‡ Elizabeth E. M. Bates,† Shizuo Akira,¶# Paulo Vieira,§ Yong-Jun Liu,
Giorgio Trinchieri,† and Anne O’Garra2*
We have previously reported that mouse plasmacytoid dendritic cells (DC) produce high levels of IL-12p70, whereas bone mar-
row-derived myeloid DC and splenic DC produce substantially lower levels of this cytokine when activated with the TLR-9 ligand
CpG. We now show that in response to CpG stimulation, high levels of IL-10 are secreted by macrophages, intermediate levels by
myeloid DC, but no detectable IL-10 is secreted by plasmacytoid DC. MyD88-dependent TLR signals (TLR4, 7, 9 ligation),
Toll/IL-1 receptor domain-containing adaptor-dependent TLR signals (TLR3, 4 ligation) as well as non-TLR signals (CD40
ligation) induced macrophages and myeloid DC to produce IL-10 in addition to proinflammatory cytokines. IL-12p70 expression
in response to CpG was suppressed by endogenous IL-10 in macrophages, in myeloid DC, and to an even greater extent in splenic
CD8 and CD8 DC. Although plasmacytoid DC did not produce IL-10 upon stimulation, addition of this cytokine exogenously
suppressed their production of IL-12, TNF, and IFN-, showing trans but not autocrine regulation of these cytokines by IL-10 in
plasmacytoid DC. The Journal of Immunology, 2006, 177: 7551–7558.
M icrobial products activate the innate immune responseand stimulate the production of cytokines, thereby de-termining the class of adaptive response mounted
against a particular pathogen (1–4). Dendritic cells (DC)3 originate
in the bone marrow (BM) and migrate through blood to secondary
lymphoid organs and tissue. DC continuously sense pathogens and
take up, process, and present Ag to T lymphocytes, thereby initi-
ating the adaptive immune response (1–4). Macrophages play a
role in the early phases of the immune response by producing
cytokines and killing pathogens (5).
Th1 cell responses can be promoted through the activation of
different DC subsets by a wide range of pathogens or their prod-
ucts, largely through the secretion of proinflammatory molecules
such as bioactive IL-12p70 (consisting of the IL-12p40 and IL-
12p35 subunits) and in some cases type I IFN (6–16). Activation
of DC and macrophages by pathogens involves the specific inter-
action between pattern recognition receptors, such as the members
of the TLR family, and pathogen-derived products (17, 18). Upon
TLR ligation, signaling cascades are activated via Toll/IL-1 recep-
tor domain-containing adaptors, such as MyD88 and Toll/IL-1 re-
ceptor domain-containing adaptor (TRIF), leading to cytokine pro-
duction. All TLR, except TLR3, use MyD88, whereas TRIF is
involved only in TLR3 and TLR4 signaling, resulting after binding
of their specific ligands, dsRNA (or poly(I:C)) and LPS, respec-
tively (17). The TRIF adaptor has been shown to be responsible for
a MyD88-independent signaling pathway giving rise to IFN-
(19–21). Distinct DC subpopulations in both mice and humans
(reviewed in Ref. 2) have been shown to express different TLR,
and consequently to respond to distinct microbial products (22–
26). For example, TLR4 is expressed by macrophages, human
monocyte-derived DC, and mouse myeloid DC, but not by plas-
macytoid DC (22, 23). In contrast, TLR9, specific for unmethyl-
ated DNA containing CpG motifs, abundantly present in microbial
genomes, is expressed by both human and mouse plasmacytoid DC
(22, 23, 27). In contrast to the limited expression of TLR9 mRNA
by human plasmacytoid DC and human B cells, in the mouse
TLR9 mRNA is expressed not only by these cells but also by
mouse macrophages, myeloid DC, and splenic CD8 and
CD8 DC (23). Collectively, these findings explain 1) the ability
of mouse myeloid DC, macrophages, and splenic DC, but not plas-
macytoid DC, to drive Th1 cell development in response to LPS
(23, 28), and 2) the ability of plasmacytoid DC, and to a lesser
extent myeloid DC, to respond to CpG and drive Th1 develop-
ment, as we have previously shown (23).
Surprisingly, although splenic CD8 DC, CD8 DC, and
myeloid DC express similar levels of TLR9 mRNA, CpG stimu-
lation induced only low levels of IL-12p70 (23). Thus, in addition
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to differential TLR expression, other factors may play a role in the
production of bioactive IL-12p70 (29). For example, T cells have
been shown to enhance the production of IL-12p70 by APCs
through cell-cell contact involving at least the interaction of
CD40L on activated T cells with CD40 on the APC (30–34). In
contrast, negative regulation exerted by anti-inflammatory cyto-
kines such as IL-10 has been shown to suppress IL-12p70 produc-
tion by DC and macrophages, resulting in the inhibition of Th1 cell
development (12, 35–37).
It has been suggested that the induction of the anti-inflammatory
cytokine IL-10 after stimulation with lectins derived from patho-
gens can be mediated by a TLR-independent signaling pathway
(38, 39). Furthermore, it has been suggested that TLR2 agonists
are specialized to induce IL-10, as shown by stimulation with li-
popeptides or the LcrV Ag of Yersinia pestis (40, 41).
In this study, we show that significant levels of IL-10 are
secreted by macrophages and myeloid DC upon stimulation
with MyD88- and TRIF-dependent TLR ligands, as well as non-
TLR signals. Endogenous IL-10 suppressed IL-12p70 produc-
tion by myeloid DC, macrophages, and splenic DC. In contrast,
plasmacytoid DC did not produce IL-10 upon stimulation and
showed unrestrained IL-12p70 production. Nevertheless, plas-




BALB/c, C57BL/6, MyD88-deficient, and TRIF-deficient mice were used
to provide macrophages and DC. Breeding pairs of MyD88-deficient and
TRIF-deficient mice were provided by S. Akira (Osaka University, Osaka,
Japan) (21, 42). All mice were bred at the National Institute for Medical
Research (London, U.K.) and housed under specific pathogen-free condi-
tions. Female mice were used between 8 and 12 wk of age.
Reagents and cell lines
Culture medium was RPMI 1640 with 5% heat-inactivated FCS, 0.05 mM
2-ME, 10 mM HEPES buffer, 100 U/ml penicillin, 100 g/ml streptomy-
cin, 2 mM L-glutamine, and 1 mM sodium pyruvate. DC were stimulated
with Salmonella minnesota LPS (Alexis), poly(I:C) (Invivogen Life Tech-
nologies), or phosphorothioate CpG DNA (CpG1668: TCCATGACGTTCC
TGATGCT; Invitrogen Life Technologies). Mouse Flt3 ligand was pro-
duced at DNAX, and mouse GM-CSF was obtained from Schering Plough.
mAb used for isolation of DC subsets were anti-B220-FITC, anti-CD11c-
PE, anti-CD11b-allophycocyanin, anti-CD8-allophycocyanin (all BD
Pharmingen or eBioscience), or 120G8-Alexa488 (43). The anti-IL-10R
mAb (1B1.3) was provided by DNAX. The cell lines 3T3-CD40L and
3T3-vector cell (control) were a gift from Dr. P. Hwu (National Cancer
Institute, Bethesda, MD) and were derived from National Institutes of
Health 3T3 cells by stable transduction with murine CD40L or empty
vector.
Generation of BM-derived macrophages
BM-derived macrophages were generated in the presence of L cell-condi-
tioned medium containing M-CSF as described by Warren et al. (44).
Briefly, BM cells were isolated by flushing femurs and tibia with culture
medium, and RBC lysed. Cells were plated at 0.5  106 cells/ml in petri
dishes (Barloworld Scientific; volume, 8 ml). At day 4, 10 ml of fresh L
cell-conditioned medium were added. At day 7, adherent cells were har-
vested by gentle flushing. The purity was always 95% as determined by
staining for F4/80 cells by flow cytometry.
Generation of BM-derived DC
BM cells were isolated by flushing femurs and tibia with culture medium.
RBC were lysed using 0.83% ammonium chloride. GM-CSF-derived my-
eloid DC were generated as described by Inaba et al. (45). In brief, BM
cells were plated at 106 cells/ml in medium supplemented with 10 ng/ml
GM-CSF in 12-well plates in a volume of 2 ml. At days 2 and 4, super-
natant containing nonadherent cells was removed, the wells were washed
gently, and fresh medium containing GM-CSF (10 ng/ml) was added. At
day 6, nonadherent cells were collected, centrifuged, resuspended in fresh
medium with GM-CSF (10 ng/ml), and cultured overnight in petri dishes
(Nunc). Cells were purified by flow cytometry as CD11c cells using a
MoFlo cytometer (DakoCytomation). Plasmacytoid DC were generated by
culturing BM cells in culture medium containing 100 ng/ml Flt3 ligand for
10 days at 106 cells/ml in 12-well plates in a volume of 2 ml. At day 5, 1
ml of medium was replaced by 1 ml of fresh medium containing Flt3 ligand
(46). The resulting plasmacytoid DC were purified by flow cytometry as
CD11cCD11bB220 using a MoFlo cytometer (DakoCytomation). The
purity was always 98%.
Preparation of splenic DC subsets
For the purification of splenic DC, spleens were treated for 30 min at 37°C
with 0.4 mg/ml Liberase Cl (Boehringer Mannheim), followed by RBC
lysis as above. Cells were maintained throughout the procedure in cold
PBS, 5% FCS, and 0.5 mM EDTA. Spleen cell suspensions were enriched
for DC using anti-CD11c microbeads using an AutoMACS (Miltenyi Bio-
tec) according to the manufacturer’s instructions. The enriched DC were
stained with CD11c-PE, CD8-allophycocyanin, and 120G8-Alexa488 and
purified using a MoFlo cytometer (DakoCytomation) as the
CD11cCD8, CD11cCD8, and the CD11cdull20G8 plasmacytoid
DC (43). The purity was consistently 98%.
In vitro stimulation of DC and macrophages, and quantitation
of cytokine production
For in vitro stimulations, 105 sorted DC or macrophages were cultured
in 200 l in 96-well flat-bottom culture plates (Nunc) and stimulated
with medium alone, LPS (100 ng/ml), poly(I:C) (50 g/ml), or
CpG1668 DNA (1 M) either alone, or on a monolayer of CD40L-
transfected 3T3 cells or control empty vector-transfected cells. To some
cultures anti-IL-10R mAb (1B1.3; 10 g/ml) or IL-10 (10 ng/ml) was
added. After culture for 24 h, supernatants were collected, and the cy-
tokine concentration was determined by immunoassay. Commercially
available ELISA kits were used for the detection of IL-12p70, TNF,
IL-10 (eBioscience; Ready-Set-Go), and IFN- (PBL supplier). IFN-
was measured by a sandwich ELISA with an anti-IFN- capture mAb
(F18; Hycult), and a rabbit anti-IFN- polyclonal Ab (PBL supplier)
followed by goat anti-rabbit HRP (Sigma-Aldrich). IL-12p40 was de-
tected using C15.6.7 as capture mAb and biotinylated C17.8 as detec-
tion mAb.
Statistical analysis
Data from multiple experiments were analyzed by comparison to a defined
control value using Dunnett’s test. Analysis was performed using
GraphPad Prism software (GraphPad). In defined cases, pairwise compar-
ison was by Student’s paired t test. Values of p  0.05 were considered
significant.
Results
CpG induces IL-10 production from macrophages and myeloid
DC, but not from plasmacytoid DC
Although macrophages, myeloid DC, splenic DC, and plasmacytoid
DC all express TLR9 (23, 25) and respond to CpG to produce IL-
12p40 and TNF, we show in this study that they differ substantially
with respect to the production of IL-10 and IL-12p70 (Fig. 1). We
postulated that this differential IL-10 production may account for re-
duced production of IL-12p70 by splenic DC, myeloid DC, and
macrophages.
Macrophages produced high levels of IL-10 (2260 pg/ml) upon
stimulation via TLR9, whereas no IL-12p70 was detected (Fig. 1).
Myeloid DC also produced IL-10 upon CpG stimulation, albeit at
lower levels than by macrophages, and only low levels of IL-
12p70 were detected (200 pg/ml). In contrast, plasmacytoid DC
produced no detectable IL-10 upon TLR9 ligation with CpG,
whereas high levels of IL-12p70 were produced in response to
CpG (1080 and 1610 pg/ml for BM-derived and splenic plasma-
cytoid DC, respectively). The production of IL-12p40 and TNF did
not mirror that of IL-10 or IL-12p70. The ratio of IL-12p40/IL-
12p70 was not identical in macrophages and the different DC pop-
ulations. TNF was produced at relatively high levels by macro-
phages, myeloid DC, and plasmacytoid DC, and at low levels by
splenic CD11c DC (Fig. 1). A similar cell type-specific pattern of
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IL-10, IL-12, and TNF production was observed upon stimulation
with the TLR7 ligand R-848 (data not shown). Thus, macrophages,
myeloid DC, and plasmacytoid DC have distinct intrinsic proper-
ties that affect their capacity to produce IL-10, IL-12p70, IL-
12p40, and TNF that are not dictated by their TLR expression.
IL-10 production is induced by TLR ligands via
MyD88-dependent and TRIF-dependent TLR signals
in macrophages and myeloid DC
Although it is well documented that the production of proinflamma-
tory cytokines upon TLR ligation is MyD88 dependent (21, 47, 48),
it has been suggested that the production of the suppressive cyto-
kine IL-10 is favored by usage of pathways involving triggering
via C-type lectins, such as dectin-1 and DC-SIGN (38, 39), or
TLR2 (40, 41). In this study, we show clearly that the induction of
IL-10 by macrophages is entirely MyD88 dependent in response to
CpG and partially MyD88-dependent in response to LPS, because
IL-10 production by MyD88-deficient macrophages was absent or
severely impaired upon stimulation with these TLR ligands (Fig.
2). IL-10 was also induced upon stimulation of wild-type macro-
phages with poly(I:C). Macrophages from TRIF knockout (KO)
mice showed almost complete abrogation of IL-10 production in-
duced by poly(I:C), whereas IL-10 production by MyD88 KO
macrophages stimulated with poly(I:C) was not affected (Fig. 2).
Residual IL-10 production in response to poly(I:C) in TRIF KO
macrophages may be due to signaling via a TRIF-independent
pathway using Mda-5, recently reported as inducing other proin-
flammatory cytokines (49). The production of IL-10 upon stimu-
lation with LPS depended not only on MyD88 but also on
TRIF-dependent signaling pathways. This indicates that IL-10 pro-
duction in macrophages can be achieved via MyD88-dependent as
well as TRIF-dependent TLR signals. Recently, it was shown that
the production of IL-10 and IFN- are both regulated by TNFR-
associated factor 3, downstream of MyD88 and TRIF, implying
coordinate expression (50). Indeed, similar to IL-10, the produc-
tion of IFN- by macrophages in response to CpG was MyD88
dependent and was completely dependent on TRIF signaling in
response to poly(I:C). In contrast to IL-10 production, which is
dependent on TRIF and MyD88 in response to LPS, IFN- pro-
duction in macrophages upon LPS stimulation was completely de-
pendent on TRIF and not MyD88 (Fig. 2).
Similar to macrophages, stimulation of myeloid DC with CpG
and LPS induced production of IL-10 and was entirely MyD88
dependent in case of TLR9 triggering and dependent on MyD88
and TRIF upon TLR4 triggering (Fig. 2). In contrast to macro-
phages, myeloid DC did not or only weakly responded to poly(I:C)
to produce IL-10, IL-12p40, IL-12p70, or TNF (Fig. 2 and data not
shown).
IL-10 production is induced in macrophages, myeloid DC, and
splenic DC subsets, but not in plasmacytoid DC upon CD40
ligation
TLR ligation of DC induces both cytokine production and the ex-
pression of costimulators like CD40, and differential regulation by
T cell-derived signals, including CD40L, determines the different
levels of IL-12p70 induced in different cell populations (31–33).
Macrophages and DC were stimulated via CD40 using a CD40L-
transfected cell line and a control empty vector-transfected cell
line as a negative control. Interestingly, high levels of IL-10 were
produced upon CD40 signaling in macrophages, myeloid DC, and
splenic CD8 and CD8 DC. IL-10 again was not secreted by
plasmacytoid DC upon CD40 triggering (Fig. 3). In keeping with
previous studies in DC (51) upon ligation of CD40 in the absence
of TLR ligands, all mouse DC subsets analyzed produced signif-
icant levels of IL-12p70. This was not the case for macrophages
(Fig. 3). Similar to the findings with TLR ligands, the ratio of
IL-12p40/IL-12p70 was not identical in the different DC subsets,
and TNF was detected only by CD40L-stimulated macrophages
(Fig. 3).
In summary, stimulation of macrophages and myeloid DC
resulted in IL-10 production in response to MyD88- and TRIF-
dependent TLR ligands. These cells, and additionally splenic
CD8 and CD8 DC, produced IL-10 when stimulated via
CD40 (Fig. 3). In contrast, no IL-10 was produced by plasma-
cytoid DC upon triggering of CD40, CpG, or CpG in the context
of CD40 (data not shown), whereas IL-12p70 was secreted at
very high levels by plasmacytoid DC upon ligation of TLR9
and/or CD40 (Figs. 1 and 3).
FIGURE 1. CpG induces high levels of IL-10 in macrophages, intermediate levels in myeloid DC, and no detectable IL-10 in plasmacytoid DC.
Macrophages or sorted DC (105) obtained from BALB/c mice were stimulated in a volume of 200 l with 1 M CpG DNA for 24 h. The differences
between IL-10 production by macrophages and myeloid DC, and between the other DC populations were significant (p  0.05 by Dunnett’s test). Cytokine
levels were determined by immunoassay. The sensitivities of the ELISA were: IL-10, 50 pg/ml; IL-12p70, 50 pg/ml; IL-12p40, 1 ng/ml; and TNF, 100
pg/ml. Data are representative of four to eight experiments for each population.
7553The Journal of Immunology












IL-12 production induced by simultaneous TLR and CD40
ligation is suppressed by endogenous IL-10 in macrophages,
myeloid DC, and splenic CD8 and CD8 DC
populations, but not in plasmacytoid DC
To address the role of endogenous IL-10 in regulating cytokine pro-
duction, macrophages, myeloid DC, splenic CD8 and CD8 DC
and plasmacytoid DC were stimulated with CpG and CD40L in the
presence or absence of a neutralizing anti-IL-10R mAb.
IL-12p70 production upon CpG stimulation by macrophages
was weakly enhanced when IL-10R signaling was blocked, but not
when triggered through CD40 alone (Fig. 4A). However, upon dual
stimulation via TLR9 and CD40 in the absence of IL-10R signal-
ing, substantial amounts of IL-12p70 were secreted by macro-
phages (780 pg/ml). Upon CpG stimulation, TNF and IL-12p40
production by macrophages was significantly enhanced upon neu-
tralization of IL-10 activity, whereas CD40 triggering did not fur-
ther increase TNF and IL-12p40 production (Fig. 4A and data not
shown).
The low level of IL-12p70 induced in myeloid DC by CpG (128
pg/ml) was only slightly enhanced in the absence of endogenous
FIGURE 3. CD40 ligation of macrophages, myeloid DC, and splenic DC populations induces IL-10, whereas no IL-10 production is induced in
plasmacytoid DC. Macrophages or DC (105) obtained from BALB/c mice were stimulated for 24 h with control-transfected or CD40L-transfected 3T3 cells
in a volume of 200 l. IL-10, IL-12p40, IL-12p70, and TNF levels were determined by immunoassay. The lack of IL-10 production by plasmacytoid DC
in response to CD40L stimulation was significantly different from IL-10 production by macrophages, myeloid DC, and splenic DC (Dunnett’s test, p 
0.05). The sensitivities of the ELISAs were as described in the legend of Fig. 1. Data are representative of four to eight experiments for each DC population.
FIGURE 2. IL-10 production is induced by TLR
ligands via MyD88- or TRIF-dependent pathways. BM-
derived macrophages or myeloid DC (105) from wild-
type (WT) C57BL/6, MyD88-deficient, and TRIF-defi-
cient mice were stimulated in a volume of 200 l with
1 M CpG DNA, 100 ng/ml LPS, or 50 g/ml
poly(I:C) for 24 h. Cytokine levels were determined by
immunoassay. The sensitivities of the ELISA were 40
pg/ml for IL-10, and 15 pg/ml for IFN- ELISA. Upon
LPS stimulation, myeloid DC from MyD88-deficient
mice produce 500 pg/ml TNF, as compared 2500
pg/ml for wild-type myeloid DC (data not shown). Data
are representative of three experiments. , Statistical
significance by t test, comparing cytokine responses by
wild-type cells with KO cells (p  0.05).
7554 DIFFERENTIAL PRODUCTION OF IL-10 BY DC AND MACROPHAGES












IL-10 signaling. Dual stimulation of myeloid DC with CpG plus
CD40L resulted in augmentation of IL-12p70 production (496 pg/
ml), compared with CD40L alone (181 pg/ml). Most significantly,
however, when myeloid DC were stimulated with CpG and
CD40L, abrogation of IL-10R signaling resulted in a high level of
IL-12p70 production (1 or 2 ng/ml) (Fig. 4A). Significant enhance-
ment of IL-12p70 production by myeloid DC when IL-10R sig-
naling was abrogated was also observed upon TLR2 and TLR4
ligation together with costimulation through CD40 (data not
shown).
Similarly, splenic CD8 and CD8 DC produced substan-
tially enhanced IL-12p70 when IL-10R signaling was neutralized
upon triggering of TLR9 and CD40. This was most striking for
CpG-stimulated splenic CD8 DC, which produced up to 23.5
ng/ml IL-12p70. It was consistently found that splenic CD8 DC
produced higher levels of IL-12p70 than splenic CD8 DC,
which is in agreement with previous studies (51–53). However,
CD8 DC produce significant levels of IL-12p70 (3000 pg/ml)
when stimulated with CpG and CD40L upon neutralization of en-
dogenous IL-10 activity. Although blocking IL-10R signaling had
such a striking effect on the induction of IL-12p70 from myeloid
DC and splenic CD8 and CD8 DC, the effect on TNF levels
was less pronounced in contrast to the effect on macrophages. Fur-
thermore, myeloid DC did not respond to CD40 ligation to the
extent that splenic CD8 and CD8 DC did, suggesting that the
latter may be more dependent on T cell derived signals.
Plasmacytoid DC stimulated with CpG alone produced signifi-
cant amounts of IL-12p70 (571 pg/ml), which was even further
enhanced when simultaneously stimulated via CD40 (Fig. 4A).
However, neutralization of IL-10R signaling had little effect on
IL-12p70 and no effect on TNF production upon dual activation of
plasmacytoid DC with CpG plus CD40L in contrast to the effects
on myeloid DC and splenic CD8 and CD8 DC. Similarly,
CpG-induced IFN- and IL-12p40 production by plasmacytoid
DC was augmented by additional CD40 triggering, but, like
IL-12p70 and TNF production, was not enhanced by blocking IL-
10R signaling (Fig. 4B and data not shown).
Exogenous IL-10 suppresses the induction of proinflammatory
cytokines by plasmacytoid DC
The absence of endogenous IL-10 production by plasmacytoid DC
does not exclude that IL-10 produced by other cells can regulate
IL-12p70 production by plasmacytoid DC. Addition of exogenous
IL-10 to plasmacytoid DC showed suppression of CpG- and CpG/
CD40L-induced production of IL-12p70, TNF, and IFN- (Fig. 5).
This indicates that although plasmacytoid DC do not produce
FIGURE 4. Upon ligation of TLR in the context of CD40 triggering, IL-10 profoundly suppresses IL-12p70 production by myeloid DC and splenic
CD8 and CD8 DC, but not or only weakly by plasmacytoid DC. Macrophages, myeloid DC, and splenic CD8 and CD8 DC or plasmacytoid
DC (105) were stimulated for 24 h in a volume of 200 l with medium, anti-IL-10R (10 g/ml), CD40L-transfected 3T3 cells, or CD40L-transfected 3T3
cells plus anti-IL-10R mAb in the presence of CpG. IL-12p70, TNF (A), and IFN- (B) levels were determined by immunoassay. The sensitivity of the
IFN- ELISA is 50 U/ml. The sensitivity of the IL-12p70 and TNF ELISA is as described in the legend of Fig. 1. Significant increase of IL-12p70 was
observed when comparing CpG/CD40L vs CpG/CD40L/anti-IL10R stimulation of myeloid DC, splenic CD8 DC and splenic CD8 DC, but not
macrophages or plasmacytoid DC (p  0.05 by Dunnett’s test). Data are representative of four to eight experiments for each population.
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IL-10 and are thus not subject to autocrine regulation of proin-
flammatory cytokines by this suppressive cytokine, they are re-
sponsive to IL-10 produced by other cells in their microenvironment.
Discussion
The present study shows that macrophages, myeloid DC and plas-
macytoid DC have a differential capacity to produce IL-10 and
IL-12 in response to TLR signaling. TLR-mediated MyD88-de-
pendent and TRIF-dependent as well as non-TLR signals induce
high levels of IL-10 by macrophages and intermediate levels by
myeloid DC, whereas no detectable IL-10 is produced by plasma-
cytoid DC. Furthermore, we show that the differential IL-10 pro-
duction partly explains the superior capacity of plasmacytoid DC
to produce high levels of IL-12p70 as compared with macrophages
or myeloid DC.
We observed striking differences in the cytokine profile of mac-
rophages, myeloid DC, and splenic DC. CpG stimulation of mac-
rophages resulted in high levels of IL-10, undetectable IL-12p70,
relatively low IL-12p40, and relatively high levels of TNF. My-
eloid DC produced intermediate levels of IL-10, low IL-12p70,
very high levels of IL-12p40, and moderate amounts of TNF. In
contrast, splenic DC produced moderate amounts of IL-12p40, but
undetectable or very low amounts of IL-10, IL-12p70, and TNF.
The limited ability of splenic DC to produce cytokines upon CpG
stimulation was overcome by additional triggering via CD40,
which resulted in substantial IL-12p70, IL-12p40, and TNF pro-
duction, which surprisingly also induced IL-10. Interestingly, the
synergy between TLR and CD40 triggering was much stronger for
splenic DC than for macrophages and myeloid DC, showing their
strong dependence on T cell-derived factors to induce cytokine
production. Endogenous IL-10 was a crucial factor that strongly
suppressed IL-12p70 production by macrophages, myeloid DC,
and splenic CD8 and CD8 DC upon CpG and CD40 ligation.
With respect to IL-12p70 production, splenic DC, and especially
splenic CD8 DC, were again most highly regulated by endog-
enous IL-10. In good agreement with this, it was reported that
neutralization of IL-10, induced by Schizosaccharomyces pombe
in splenic DC, resulted in enhanced Th1 cell development in vitro
(54). Moreover, we previously showed in vivo that Ag-specific
Th1 responses in the context of TLR ligation are suppressed by
IL-10, and strong Th1 responses in vivo, induced by TLR ligation,
are observed only when IL-10R signaling is abrogated (55, 56).
IL-10 production by macrophages was induced via TLR medi-
ated MyD88- or TRIF-dependent pathways, as well as via non-
TLR signals. Triggering through TLR9 (and TLR7; data not
shown) showed that the induction of high levels of IL-10 was
completely MyD88 dependent in macrophages and myeloid DC
(Fig. 2); this was also the case for induction of IFN- (data not
shown). Conversely, IL-10 induction via the TLR3 ligand
poly(I:C) was dependent on TRIF and not MyD88 in macrophages
(Fig. 2), which was also the case for the induction IFN- (Fig. 2).
LPS induction of IL-10 via TLR4 was dependent on MyD88 and
TRIF (Fig. 2), contrasting with IFN- induction by LPS, which
was dependent only on TRIF (Fig. 2). Recently, it was shown that
TNFR-associated factor 3, an adaptor molecule downstream of
MyD88 and TRIF, regulates the production of both IL-10 and type
I IFN, which is in keeping with some of our findings (50). How-
ever, we show in this study that whereas MyD88 and TRIF regu-
late the production of IL-10 by macrophages in response to LPS,
the production of IFN- via TLR4 is dependent on TRIF and not
MyD88, suggesting that there may be independent signaling mech-
anisms regulating the production of IL-10 and IFN-. Besides
stimulation via TLR, CD40 triggering also resulted in IL-10 pro-
duction. This indicates that induction of IL-10 can be achieved by
a broad spectrum of stimuli including multiple TLR ligands, and
not, as previously implied, preferentially as a result of ligation of
TLR2- and MyD88-independent signals (38–41, 57). Thus, al-
though it has been shown that triggering with pathogens of the
C-type lectin DC-SIGN can induce IL-10 (38) and that dectin-1
stimulation with zymosan induces IL-10 via syk signaling (39), we
show in this study that these are not exclusive signals to induce the
expression of IL-10 in macrophages or DC.
We show that plasmacytoid DC do not produce IL-10 and dis-
play unrestrained IL-12p70 production upon TLR ligation, which
is in keeping with their ability to induce strong Th1 development
upon CpG stimulation in vitro (23). In addition, plasmacytoid DC
produce relatively high levels of TNF and IFN- upon CpG stim-
ulation alone. Additional triggering via CD40 further enhances
their production of IL-12p70, IL-12p40, and IFN-, but not TNF.
Mouse plasmacytoid DC, however, are responsive to the inhib-
itory effect of IL-10 on cytokine production, as are human IFN-
producing cells or plasmacytoid DC (58, 59), indicating that other
IL-10-producing cells in their microenvironment may suppress
their activity if colocated. Plasmacytoid DC clusters, 6 h after CpG
treatment in vivo, are mostly present in the marginal zone, sepa-
rated from T cells and conventional DC (60). At later time points,
plasmacytoid DC partially colocalize with T cells and conven-
tional DC in the T cell area of the spleen. The specific localization
of DC during the inflammatory response may be important for
IL-10, produced by myeloid DC and/or macrophages, to act in
trans on plasmacytoid DC, resulting in restrained IL-12p70 pro-
duction and consequently suboptimal Th1 responses.
The differential production of IL-10 suggests that macrophages,
myeloid DC, and plasmacytoid DC are intrinsically different and
may possess distinct intracellular signaling mechanisms to activate
different sets of cytokine genes. An alternative explanation could
FIGURE 5. Exogenous IL-10 suppresses CpG-in-
duced cytokine production by plasmacytoid DC. Splenic
plasmacytoid DC (105) were stimulated for 24 h in a vol-
ume of 200 l with medium, IL-10 (10 ng/ml), CD40L-
transfected 3T3 cells, or CD40L-transfected 3T3 cells plus
IL-10 in the presence of CpG. IL-12p70, TNF, and IFN-
levels were determined by immunoassay. The sensitivity
of the ELISA is as described in the legends of Figs. 1 and
4. Data are representative of two experiments.
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be that plasmacytoid DC produce other endogenous cytokines such
as IFN- or IFN-, which may suppress IL-10 production by plas-
macytoid DC. Interestingly, although endogenous IL-10 sup-
presses IL-12p70 production by macrophages, myeloid DC, and
splenic DC, the suppressive effect of IL-10 on TNF production is
cell type specific. In this, the induction of TNF by macrophages is
highly suppressed by endogenous IL-10, but TNF production by
myeloid and splenic DC does not appear to be regulated by en-
dogenous IL-10. The underlying mechanisms for this are currently
being studied.
Triggering via TLR induces not only IL-12, thereby promoting
Th1 immunity, but also IL-10 that counteracts the effects of IL-12
and suppresses the development of an immune response to patho-
gens. By doing so, IL-10 prevents excessive activation of the im-
mune response, which limits immune pathology, but alternatively
may prevent the complete eradication of pathogens by inhibiting
Th1 immunity. Our findings that macrophages and DC have cell-
intrinsic properties controlling their production of IL-10, which
subsequently affects their production of IL-12, provide important
insight into the mechanisms underlying the complex balance of
IL-10 vs IL-12 induction, which is fundamental for the understand-
ing of the dynamics of the immune response to pathogens.
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